Ticker AMAG – AMAG – sales, description, marketcap – Tickerday.com

AMAG

AMAG

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 325.83M; Volume: 66.17K; AvgVol 3m: 429.80K; Beta: –;

Cost estimate:

P/E: –; EPS: -7.63; EPS growth quarter/prev quarter: 89.20%;

EPS growth this year: -178.40%; EPS growth past 5 years: -35.40%;

EPS ttm: -7.63;

P/S: 1.50; P/B: 1.80; P/Cashflow: 03.04; P/FCF: ;

Sales: 297.04M; Sales growth quarter/prev quarter: -32.40%; Sales growth past 5 years: 21.40%;

Profitability:

Gross Margin: 64.00%; Profit Margin: -87.40%; Operating Margin: -79.70%;

ROA – return on assets: -32.20%; ROE – return on equity: -81.50%; LT Debt/Equity: 1.14; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.10%; Insider Transactions:-92.10%;

Institutional Ownership: ; Institutional Transactions: -2.40%;

Data update: 07.10.2020.